|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 248.04 USD | -0.98% |
|
-3.05% | +7.77% |
| 07-10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| 07-10 | BofA Securities Adjusts AbbVie Price Target to $276 From $234 | MT |
| Market Cap | 438B 383B 354B 327B 620B 41,803B 630B 4,225B 1,659B 20,593B 1,646B 1,610B 70,796B | P/E 2026 * |
30.3x | P/E 2027 * | 23.1x |
|---|---|---|---|---|---|
| Enterprise Value | 495B 433B 399B 369B 699B 47,180B 711B 4,769B 1,873B 23,243B 1,857B 1,817B 79,903B | EV / Sales 2026 * |
7.36x | EV / Sales 2027 * | 6.68x |
| Free-Float |
95.71% | Yield 2026 * |
2.76% | Yield 2027 * | 2.92% |
Last Transcript: AbbVie Inc.
| 1 day | -0.98% | ||
| 1 week | -3.05% | ||
| Current month | -1.80% | ||
| 1 month | +11.53% | ||
| 3 months | +21.28% | ||
| 6 months | +12.99% | ||
| Current year | +7.77% |
| 1 week | 245 |  | 261.2 |
| 1 month | 215 | | 265 |
| Current year | 186.49 | | 265 |
| 1 year | 184.84 | | 265 |
| 3 years | 134.2 | | 265 |
| 5 years | 105.59 | | 265 |
| 10 years | 50.38 | | 265 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Scott Reents
DFI | Director of Finance/CFO | 59 | 2022-06-22 |
Linda Ray
CTO | Chief Tech/Sci/R&D Officer | - | 2024-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Roxanne Austin
BRD | Director/Board Member | 65 | 2012-12-31 |
William Burnside
BRD | Director/Board Member | 74 | 2012-12-31 |
Edward Rapp
BRD | Director/Board Member | 68 | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.98% | -3.05% | - | - | 438B | |
| -2.33% | -2.09% | +49.88% | +169.76% | 1,060B | |
| -0.82% | -2.30% | +63.79% | +62.56% | 619B | |
| -0.01% | +1.45% | +30.62% | +25.78% | 333B | |
| +0.06% | -0.61% | +28.94% | +46.97% | 282B | |
| -1.41% | -10.33% | +18.59% | +22.40% | 267B | |
| +0.46% | +0.67% | -27.07% | -38.18% | 218B | |
| -0.06% | -2.88% | +23.07% | +61.02% | 196B | |
| -3.72% | -1.10% | +18.41% | +69.98% | 161B | |
| -0.33% | -0.62% | -5.77% | -32.84% | 138B | |
| Average | +0.14% | -2.85% | +22.27% | +43.05% | 363.71B | |
| Weighted average by Cap. | +0.05% | -2.74% | +35.57% | +78.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 67.23B 58.81B 54.24B 50.1B 95.06B 6,412B 96.66B 648B 255B 3,159B 252B 247B 10,860B | 72.78B 63.66B 58.72B 54.23B 103B 6,942B 105B 702B 276B 3,420B 273B 267B 11,756B |
| Net income | 14.58B 12.75B 11.76B 10.86B 20.61B 1,391B 20.96B 141B 55.19B 685B 54.74B 53.55B 2,355B | 19.19B 16.78B 15.48B 14.3B 27.13B 1,830B 27.59B 185B 72.64B 902B 72.05B 70.48B 3,099B |
| Net Debt | 56.38B 49.32B 45.49B 42.01B 79.72B 5,377B 81.06B 544B 213B 2,649B 212B 207B 9,107B | 47.86B 41.86B 38.61B 35.66B 67.67B 4,564B 68.81B 461B 181B 2,249B 180B 176B 7,730B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | US$248.00 | -1.00% | 0 |
| 26-07-10 | US$246.32 | -1.36% | 22,221 |
| 26-07-09 | US$249.71 | -1.72% | 4,486 |
| 26-07-08 | US$254.08 | -0.24% | 11,616 |
| 26-07-07 | US$254.70 | -0.43% | 17,722 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- 0QCV Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
